The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
A water-soluble molecule called STP3 can bind certain bitter alkaloid medicines and reduce bitter responses in laboratory and animal experiments. The proposed trick is to hold the medicine in a molecular “container” while it is in the mouth, then release it in acidic conditions. That is a promising research concept—not a treatment shown to work in people.
What STP3 is and how it works
STP3 is a sulphonatopropoxy terphen[3]arene: a ring-shaped host molecule designed to surround or associate with smaller guest molecules. Its sulfonated side chains make it water-soluble, a useful property for a proposed oral medicine formulation. In the 2022 study, Junyi Chen and colleagues examined whether STP3 could bind bitter alkaloid medicines and change how bitter they taste.
| # | Preview | Product | Price | |
|---|---|---|---|---|
| 1 |
|
30 Pcs Disposable Tongue Cover Plastic Tasteproof Protection | $8.09 | Buy on Amazon |
The researchers reported complexes with six alkaloid medicines. Atropine-related medicine and colchicine were among the examples discussed in Chemistry World’s 2022 report. The primary paper describes STP3 as a potential taste-masking macrocyclic container for pharmaceutical research, not as an established medicine or product (Chen et al., Chemical Communications, 2022).
Why the pH response matters
The proposed formulation aims to do two things at different points in the digestive process: keep the bitter guest associated with STP3 in the mouth, then release it in the stomach. Chemistry World reported that the binding differed between pH 6.8, used in the study to represent the mouth, and pH 1.2, used to represent gastric acid. Under the more acidic condition, the complex became unstable and released the alkaloid.
#1 Best Overall
- Single use: ensure maximum with these disposable tongue covers, designed for single use to maintain cleanliness and convenience,tongue protective cover,tasteproof protection
- Suitable for all ages: these tongue protectors offer a universal fit, making them for individuals of all ages, adults,tongue protectors disposable,tongue cover
- Disposable and : these tongue covers are designed for single use, ensuring and convenience for every application,disposable tongue guard,oral health protection
- Comfortable and easy to use: the ergonomic design ensures these tongue covers are comfortable and easy to use, making them ideal for daily use,disposable tongue cover,bitter taste prevention disposable
- Fits all ages: these tongue protectors are suitable for people of all ages, providing a comfortable fit for both and adults,protective tongue cover disposable,taste-proof tongue glove
This is a laboratory observation about pH-dependent binding. It does not show how STP3 would behave in a person, establish how much drug would be absorbed, or prove that a medicine would retain its clinical effect after formulation.
What the experiments showed
Taste-sensing tests
The team used an electronic-tongue taste-sensing system. According to Chemistry World, the system registered a substantial reduction in bitterness when STP3 was co-administered with the alkaloid. This supports the idea that host–guest binding can mask bitter taste in experimental conditions; it is not a report of patient experience.
Animal studies
The report also describes animal experiments in which STP3 was non-toxic and did not diminish the activity of the carried drugs. Those findings are limited to the animals and conditions studied. They cannot establish human safety, dosing, effectiveness, or whether the taste-masked medicines would work as intended in patients.
What remains uncertain
The cited publication and report describe early proof-of-concept research. They do not establish clinical trials, regulatory approval, availability for consumers, or use in patients. The work concerns a subset of bitter alkaloids, so it should not be taken as evidence that STP3 can mask the taste of medicines generally.
There is also a formulation challenge: a host must bind a drug strongly enough to limit bitterness, but not interfere with the drug’s therapeutic action or release it at the wrong time. Supramolecular chemist Ana Castilla of the University of Greenwich highlighted that balance, along with optimization for commercial use, in a 2022 Chemistry World comment. She said that, to her knowledge at the time, synthetic containers like STP3 had not yet been applied in the pharmaceutical industry. That was a dated expert assessment, not a current survey of the market.
Although cyclodextrins are mentioned as background to taste-masking research, the cited sources do not provide a like-for-like performance comparison with STP3. There is therefore no supported basis here to say that STP3 works better than existing approaches.
Why this research matters
Bitter taste can make oral medicines harder to take, and a molecule that temporarily shelters a drug from taste receptors could offer a new formulation strategy. STP3’s reported water solubility and acid-sensitive release make it an interesting candidate for further investigation. For now, the evidence supports a research possibility—not a proven way for patients to take bitter medicine more easily.
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Repair Windows errors before they cause bigger problemsFix Now →Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
